Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
15 Février 2024 - 7:15PM
AllPennyStocks.com
Orphan drug designation, or ODD, is valuable on both a
humanitarian and a profitability basis. And this company is seeing
shares rally following news that it was granted the designation for
the...
To read the full story on AllPennyStocks.com, click
here.
Cardiol Therapeutics (NASDAQ:CRDL)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Cardiol Therapeutics (NASDAQ:CRDL)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024